Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
Clinical trial NCT03718767 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03718767
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-27
- Primary completion
- 2024-11-05
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.